BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Salem ML, El-Badawy A. Programmed death-1/programmed death-L1 signaling pathway and its blockade in hepatitis C virus immunotherapy. World J Hepatol 2015; 7(23): 2449-2458 [PMID: 26483866 DOI: 10.4254/wjh.v7.i23.2449]
URL: https://www.wjgnet.com/1948-5182/full/v7/i23/2449.htm
Number Citing Articles
1
Jacob C. Bjorgen, Jenna K. Dick, Ross Cromarty, Geoffrey T. Hart, Joshua Rhein. NK cell subsets and dysfunction during viral infection: a new avenue for therapeutics?Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1267774
2
Meihua Qiu, Yuqing Chen, Qiao Ye. Downregulation of the PD-1/PD-Ls pathway in peripheral cells correlates with asbestosis severityBMC Pulmonary Medicine 2021; 21(1) doi: 10.1186/s12890-021-01531-5
3
Zhijuan Lin, Xing Chen, Zhifeng Li, Yiming Luo, Zhihong Fang, Bing Xu, Mingzhe Han, Andrzej T Slominski. PD-1 Antibody Monotherapy for Malignant Melanoma: A Systematic Review and Meta-AnalysisPLOS ONE 2016; 11(8): e0160485 doi: 10.1371/journal.pone.0160485
4
Ilya Tsimafeyeu, Rustem Gafanov, Svetlana Protsenko, Anna Semenova, Ani Oganesyan, Nurzhan Nurgaliyev, Sergei Krasny, Anastasia Bondarenko, Sufia Safina, Kristina Zakurdaeva. Nivolumab in patients with metastatic renal cell carcinoma and chronic hepatitis C virus infectionCancer Immunology, Immunotherapy 2020; 69(6): 983 doi: 10.1007/s00262-020-02521-y
5
J. M. Sahler, C. R. Eade, C. Altier, J. C. March, Shelley M. Payne. Salmonella enterica Serovar Typhimurium Increases Functional PD-L1 Synergistically with Gamma Interferon in Intestinal Epithelial Cells via Salmonella Pathogenicity Island 2Infection and Immunity 2018; 86(5) doi: 10.1128/IAI.00674-17
6
E. Cimini, V. Bordoni, A. Sacchi, U. Visco-Comandini, M. Montalbano, C. Taibi, R. Casetti, E. Lalle, G. D’Offizi, M.R. Capobianchi, C. Agrati. Intrahepatic Vγ9Vδ2 T-cells from HCV-infected patients show an exhausted phenotype but can inhibit HCV replicationVirus Research 2018; 243: 31 doi: 10.1016/j.virusres.2017.10.008
7
Ayesha Obaid, Anam Naz, Aqsa Ikram, Faryal Mehwish Awan, Abida Raza, Jamil Ahmad, Amjad Ali. Model of the adaptive immune response system against HCV infection reveals potential immunomodulatory agents for combination therapyScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-27163-0
8
Laura Wuyts, Annelies Janssens, Luisa Vonghia, Peter Michielsen, Jo Raskin, Ann Driessen, Stijn Van Hees, Sven Francque, Thomas Vanwolleghem. Nivolumab and anti-HCV activity, a case reportActa Clinica Belgica 2021; 76(5): 392 doi: 10.1080/17843286.2020.1741897
9
Eirini Karamichali, Pelagia Foka, Georgia Papadopoulou, Domniki Loukaki-Gkountara, Konstantina Andresaki, Ioannis Koskinas, Urania Georgopoulou. Hepatitis Viruses Control Host Immune Responses by Modifying the Exosomal Biogenesis Pathway and CargoInternational Journal of Molecular Sciences 2022; 23(18): 10862 doi: 10.3390/ijms231810862
10
Kohei Fujita, Young Hak Kim, Osamu Kanai, Hironori Yoshida, Tadashi Mio, Toyohiro Hirai. Emerging concerns of infectious diseases in lung cancer patients receiving immune checkpoint inhibitor therapyRespiratory Medicine 2019; 146: 66 doi: 10.1016/j.rmed.2018.11.021
11
Mona Sadeghalvad, Nima Rezaei. Encyclopedia of Infection and Immunity2022; : 481 doi: 10.1016/B978-0-12-818731-9.00171-3
12
Erin S Beck, Irene Cortese. Checkpoint inhibitors for the treatment of JC virus-related progressive multifocal leukoencephalopathyCurrent Opinion in Virology 2020; 40: 19 doi: 10.1016/j.coviro.2020.02.005
13
Marco Tagliamento, Francesco Grossi, Sabrina Paolino, Erika Rijavec, Carlo Genova, Giovanni Rossi, Federica Biello, Andrea De Maria. Nivolumab Treatment in Advanced Lung Cancer Patient With Chronic Active Hepatitis C and Systemic Lupus ErythematosusImmunotherapy 2019; 11(10): 873 doi: 10.2217/imt-2019-0025
14
Kristina Zakurdaeva, Ilya Tsimafeyeu. Immunotherapy in cancer patients with chronic hepatitis C viral infectionJournal of Cancer Research and Therapeutics 2023; 19(5): 1093 doi: 10.4103/jcrt.jcrt_2095_21
15
Shima Bastaki, Mahzad Irandoust, Armin Ahmadi, Mohammad Hojjat-Farsangi, Patrick Ambrose, Shahin Hallaj, Mahdi Edalati, Ghasem Ghalamfarsa, Gholamreza Azizi, Mehdi Yousefi, Hengameh Chalajour, Farhad Jadidi-Niaragh. PD-L1/PD-1 axis as a potent therapeutic target in breast cancerLife Sciences 2020; 247: 117437 doi: 10.1016/j.lfs.2020.117437
16
Lodovica Zullo, Giovanni Rossi, Chiara Dellepiane, Marco Tagliamento, Angela Alama, Simona Coco, Luca Longo, Paolo Pronzato, Andrea De Maria, Carlo Genova. Safety and Efficacy of Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer: Focus on Challenging PopulationsImmunotherapy 2021; 13(6): 509 doi: 10.2217/imt-2020-0226
17
Yu Liu, Chenhua Wu, Nannan Chen, Yang Li, Chunling Fan, Shangqi Zhao, Tongtong Bai, Zhibo Zhao, Jinwei Chen, Siyu Su, Zecai Zhang, Yulong Zhou, Zhanbo Zhu. PD-1 Blockade Restores the Proliferation of Peripheral Blood Lymphocyte and Inhibits Lymphocyte Apoptosis in a BALB/c Mouse Model of CP BVDV Acute InfectionFrontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.727254
18
Xue Chen, Ann M. Bode, Zigang Dong, Ya Cao. The epithelial–mesenchymal transition (EMT) is regulated by oncoviruses in cancerThe FASEB Journal 2016; 30(9): 3001 doi: 10.1096/fj.201600388R
19
Itziar Ubillos, Joseph J. Campo, Pilar Requena, Maria Ome-Kaius, Sarah Hanieh, Honor Rose, Paula Samol, Diana Barrios, Alfons Jiménez, Azucena Bardají, Ivo Mueller, Clara Menéndez, Stephen Rogerson, Gemma Moncunill, Carlota Dobaño. Chronic Exposure to Malaria Is Associated with Inhibitory and Activation Markers on Atypical Memory B Cells and Marginal Zone-Like B CellsFrontiers in Immunology 2017; 8 doi: 10.3389/fimmu.2017.00966
20
Lydia Dyck, Kingston H.G. Mills. Immune checkpoints and their inhibition in cancer and infectious diseasesEuropean Journal of Immunology 2017; 47(5): 765 doi: 10.1002/eji.201646875
21
Mohamed Labib Salem, Abdel-Aziz A. Zidan, Mohamed Attia, Randa E. EL-Naggar, Mohamed Nassef, Abdel Raouf Abou El-Azm, Hasan El-Bate, Mohamed Yussif, Sohaila Galal, Mohamed Abo Senna, Maha El Demellawy. IFN-α-based treatment of patients with chronic HCV show increased levels of cells with myeloid-derived suppressor cell phenotype and of IDO and NOSImmunopharmacology and Immunotoxicology 2017; 39(4): 188 doi: 10.1080/08923973.2017.1320670
22
Yu Liu, Shanshan Liu, Boning He, Tian Wang, Shangqi Zhao, Chenhua Wu, Shan Yue, Shixun Zhang, Mingrui He, Li Wang, Wenjing Huang, Tongrui Shi, Zhanbo Zhu. PD-1 blockade inhibits lymphocyte apoptosis and restores proliferation and anti-viral immune functions of lymphocyte after CP and NCP BVDV infection in vitroVeterinary Microbiology 2018; 226: 74 doi: 10.1016/j.vetmic.2018.10.014
23
Honggeng Guan, Yuqiu Wan, Jing Lan, Qin Wang, Zhangyu Wang, Yecheng Li, Jiqing Zheng, Xueguang Zhang, Zemin Wang, Yueping Shen, Fang Xie. PD-L1 is a critical mediator of regulatory B cells and T cells in invasive breast cancerScientific Reports 2016; 6(1) doi: 10.1038/srep35651
24
Yun-Chao Zhang, Yu-Ting Zhang, Yi Wang, Ya Zhao, Li-Jie He. What role does PDL1 play in EMT changes in tumors and fibrosis?Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1226038
25
Huiming Cai, Ge Liu, Jianfeng Zhong, Kai Zheng, Haitao Xiao, Chenyang Li, Xun Song, Ying Li, Chenshu Xu, Haiqiang Wu, Zhendan He, Qinchang Zhu. Immune Checkpoints in Viral InfectionsViruses 2020; 12(9): 1051 doi: 10.3390/v12091051
26
Yuan Liu. Immunomodulatory effects of Tim-3 and PD-1 on chronic hepatitis B virus infectionInfection International 2018; 7(1): 6 doi: 10.2478/ii-2018-0012
27
Samaneh Abdolmohammadi-Vahid, Behzad Baradaran, Ian M. Adcock, Esmaeil Mortaz. Immune checkpoint inhibitors and SARS-CoV2 infectionInternational Immunopharmacology 2024; 137: 112419 doi: 10.1016/j.intimp.2024.112419
28
Lei Sun, Kun Yang, Liang Zhang, Li-ming Qi, Jia-min Chen, Ping Li, Jiang Xiao, Hong-xin Zhao, Peng Wang. Programmed death-1 expression and regulatory T cells increase in the Intestinal mucosa of cytomegalovirus colitis in patients with HIV/AIDSAIDS Research and Therapy 2020; 17(1) doi: 10.1186/s12981-020-00315-x
29
Jia Tang, Chenming Shang, Yue Chang, Wei Jiang, Jun Xu, Leidan Zhang, Lianfeng Lu, Ling Chen, Xiaosheng Liu, Qingjia Zeng, Wei Cao, Taisheng Li. Peripheral PD-1+NK cells could predict the 28-day mortality in sepsis patientsFrontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1426064